[High-throughput screening of human soluble protein tyrosine phosphatase 1B inhibitors]

Yao Xue Xue Bao. 2011 Sep;46(9):1058-64.
[Article in Chinese]

Abstract

To screen potential human soluble protein tyrosine phosphatase 1B (PTP1B) inhibitors, a high-throughput screening (HTS) model in 384-well microplate with total volume of 50 microL was established. Recombinant PTP1B was cloned and expressed in E. coli. with its specific substrate 4-nitrophenyl phosphate disodium salt hexahydrate (PNPP). The HTS model was based on enzyme reaction rate with enhanced sensitivity and specificity (Z' = 0.78). A total of 24,240 samples were screened, among them 80 samples with inhibition greater than 70% were selected for further rescreening. Finally, six compounds with high inhibitory activity were identified, whose IC50 values were 21.58, 18.39, 15.37, 11.92, 37.27, and 36.61 microg x mL(-1), separately. The results indicated that the method was stable, sensitive, reproducible and also suitable for high-throughput screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Evaluation, Preclinical / methods*
  • Enzyme Inhibitors / analysis*
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli / metabolism
  • High-Throughput Screening Assays / methods*
  • Humans
  • Inhibitory Concentration 50
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism
  • Sensitivity and Specificity
  • Vanadates / pharmacology

Substances

  • Enzyme Inhibitors
  • Vanadates
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1